{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T12:09:21Z","timestamp":1753358961793,"version":"3.30.2"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ygyno.2004.07.056","type":"journal-article","created":{"date-parts":[[2004,9,30]],"date-time":"2004-09-30T15:17:41Z","timestamp":1096557461000},"page":"539-545","source":"Crossref","is-referenced-by-count":17,"title":["Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma"],"prefix":"10.1016","volume":"95","author":[{"given":"Jeannine","family":"Villella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunle","family":"Odunsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Rodabaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah L.","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashikant","family":"Lele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2004.07.056_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2004.07.056_bib2","unstructured":"National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, SEER Public-Use, (1973\u20132000) based on the November 2002 submission. In; Issued: April 2003."},{"issue":"2","key":"10.1016\/j.ygyno.2004.07.056_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0090-8258(91)90333-Z","article-title":"Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy","volume":"42","author":"Rubin","year":"1991","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2004.07.056_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol. Oncol."},{"issue":"3 Pt 1","key":"10.1016\/j.ygyno.2004.07.056_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/gyno.2000.5926","article-title":"A critique of surgical cytoreduction in advanced ovarian cancer","volume":"78","author":"Covens","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"2 Pt. 2","key":"10.1016\/j.ygyno.2004.07.056_bib6","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0090-8258(03)00339-1","article-title":"Gemcitabine combination chemotherapy of ovarian cancer","volume":"90","author":"Mutch","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2004.07.056_bib7","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/1097-0142(20001015)89:8<1714::AID-CNCR10>3.0.CO;2-7","article-title":"A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma","volume":"89","author":"Ricci","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2004.07.056_bib8","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0090-8258(03)00399-8","article-title":"Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancer","volume":"90","author":"Markman","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2004.07.056_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0090-8258(03)00413-X","article-title":"Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study","volume":"91","author":"Belpomme","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2004.07.056_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00001813-200209000-00009","article-title":"Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer","volume":"13","author":"Nogue","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ygyno.2004.07.056_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ygyno.2004.07.056_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc., Ser. B Stat. Methodol."},{"issue":"2","key":"10.1016\/j.ygyno.2004.07.056_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1200\/JCO.1998.16.2.405","article-title":"Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study","volume":"16","author":"Rose","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2004.07.056_bib14","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.1998.16.10.3345","article-title":"Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel","volume":"16","author":"Bookman","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"9375","key":"10.1016\/j.ygyno.2004.07.056_bib15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet"},{"issue":"2 Pt. 2","key":"10.1016\/j.ygyno.2004.07.056_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0090-8258(03)00337-8","article-title":"Clinical trials of newer regimens for treating ovarian cancer: the rationale for Gynecologic Oncology Group Protocol GOG 182-ICON5","volume":"90","author":"Copeland","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2004.07.056_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/gyno.2002.6850","article-title":"Gemcitabine reverses cisplatin resistance: demonstration of activity in platinum- and multidrug-resistant ovarian and peritoneal carcinoma","volume":"88","author":"Rose","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2004.07.056_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/gyno.2002.6855","article-title":"Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients","volume":"88","author":"Nagourney","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"12","key":"10.1016\/j.ygyno.2004.07.056_bib19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1023\/A:1008339425708","article-title":"Gemcitabine-cisplatin: a schedule finding study","volume":"10","author":"Kroep","year":"1999","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2004.07.056_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2003.09.021","article-title":"Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study","volume":"92","author":"Papadimitriou","year":"2004","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825804005803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825804005803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T20:38:07Z","timestamp":1734554287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825804005803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0090825804005803"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2004.07.056","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}